Victrex (LON:VCT) Stock Price Crosses Above 200 Day Moving Average – Here’s What Happened

Victrex plc (LON:VCT)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 1,018.11 ($12.76) and traded as high as GBX 1,076 ($13.49). Victrex shares last traded at GBX 1,076 ($13.49), with a volume of 75,743 shares traded.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank reduced their target price on shares of Victrex from GBX 1,290 ($16.17) to GBX 1,170 ($14.67) and set a “hold” rating on the stock in a research note on Wednesday, December 4th.

Victrex Price Performance

The company has a current ratio of 5.30, a quick ratio of 1.99 and a debt-to-equity ratio of 16.99. The firm has a market cap of £934.70 million, a price-to-earnings ratio of 3,068.57, a P/E/G ratio of 1.92 and a beta of 0.69. The company has a 50 day moving average of GBX 939.70 and a 200 day moving average of GBX 1,015.16.

Victrex Increases Dividend

The company also recently disclosed a dividend, which will be paid on Friday, February 21st. Investors of record on Thursday, January 23rd will be issued a dividend of GBX 46.14 ($0.58) per share. The ex-dividend date of this dividend is Thursday, January 23rd. This is an increase from Victrex’s previous dividend of $13.42. This represents a dividend yield of 5.26%. Victrex’s dividend payout ratio (DPR) is presently 17,142.86%.

Insiders Place Their Bets

In related news, insider Ian Melling bought 2,000 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average price of GBX 1,135 ($14.23) per share, for a total transaction of £22,700 ($28,456.81). Also, insider Brendan Connolly purchased 980 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was bought at an average price of GBX 1,019 ($12.77) per share, with a total value of £9,986.20 ($12,518.74). Insiders own 1.64% of the company’s stock.

About Victrex

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.